Inspire Therapy: A Treatment for People Unable to Use CPAP
When left untreated, Obstructive Sleep Apnea (OSA) can contribute to an overall diminished quality of life that includes morning headaches, daytime sleepiness, and depression. OSA may also lead to significant comorbidities such as high blood pressure, heart disease, and stroke.
Treatment options for OSA include lifestyle changes, continuous positive airway pressure (CPAP), oral appliances, and anatomy altering surgery. While CPAP is the most common form of OSA treatment, studies show between 39%-50% of OSA patients are unable to use or adhere to the treatment.2-4 Of these patients, a small subset seeks surgical treatment.
Now, there is a new treatment, approved by the FDA, for patients with moderate to severe OSA who are unable to use CPAP. Inspire therapy is a fully implanted system that delivers mild stimulation to maintain multilevel airway patency during sleep.
Inspire therapy is a unique OSA treatment that is:
- National Sleep Foundation. Sleep apnea and sleep. http://sleepfoundation.org/sleep-disorders-problems/obstructive-sleep-apnea-and-sleep, Accessed June 2, 2014.
- Salepci B, Caglayan B, Kiral N, et al. CPAP Adherence of Patients With Obstructive Sleep Apnea. Respiratory Care. 2013;58:1467-1473.
- Weaver TE. Adherence to positive airway pressure therapy. Curr Opin Pulm Med. 2006;12:409-413.
- Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc. 2008;5:173-178.